arginine has been researched along with flavokawain b in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akhtar, MN; Akira, A; Israf, DA; Khalid, MH; Khalivulla, SI; Lajis, N; Mohamad, AS; Ong, HM; Perimal, EK; Sulaiman, MR; Zareen, S | 1 |
| Akhtar, MN; Akira, A; Israf, DA; Kamaldin, MN; Lajis, N; Ming-Tatt, L; Mohamad, AS; Perimal, EK; Sulaiman, MR | 1 |
2 other study(ies) available for arginine and flavokawain b
| Article | Year |
|---|---|
Possible participation of nitric oxide/cyclic guanosine monophosphate/protein kinase C/ATP-sensitive K(+) channels pathway in the systemic antinociception of flavokawin B.
Topics: Analgesics; Animals; Arginine; Cyclic GMP; Dose-Response Relationship, Drug; Enzyme Inhibitors; Flavonoids; Glyburide; Hypoglycemic Agents; Male; Methylene Blue; Mice; Mice, Inbred ICR; Nitric Oxide; Nitric Oxide Synthase; Pain; Potassium Channels; Protein Kinase C; Signal Transduction | 2011 |
Peripheral antinociception of a chalcone, flavokawin B and possible involvement of the nitric oxide/cyclic guanosine monophosphate/potassium channels pathway.
Topics: Analgesics; Animals; Arginine; Carrageenan; Chalcone; Cyclic GMP; Disease Models, Animal; Flavonoids; Hyperalgesia; Male; Nitric Oxide; Potassium Channel Blockers; Potassium Channels; Rats; Signal Transduction | 2013 |